Eli Lilly's gene-silencing drug lepodisiran has been shown to reduce lipoprotein(a) levels by more than 90% for at least six months with a single injection in a phase 2 trial, reinforcing its ...

Lipoprotein(a) is well established as a risk factor for cardiovascular disease, but patients rarely get tested for it. Now, an alliance between Novartis and genetic testing specialist 23andMe is ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. Energy Transfer LP (ET) ...

NGL Energy Partners LP engages in the transportation, storage, blending, and marketing of crude oil, natural gas liquids, refined products/renewables, and water solutions in the United States. It ...

If you purchase an independently reviewed product or service through a link on our website, Rolling Stone may receive an affiliate commission. Debi Tirar Mas Fotos beat out albums by Justin Bieber, ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Welcome to New Music Friday, your ultimate round-up of this week's single, album and home entertainment releases. Let's get stuck into this week's stacked albums slate. Hilary's re-imagined classics ...

A robust body of observational and Mendelian randomization data establishes a causal relationship between elevated Lp(a) and ASCVD, ischemic stroke and calcific aortic valve stenosis (CAVS). 3 A ...

Featured topics and Editors' Picks from all of ACC's JACC Journals. New Research Adds to Growing Evidence Surrounding Lp(a), Including Global Prevalence New original research – part of a special JACC ...